An ABC Nightline story recounts the experience of pediatric nurse, who took the medication Yaz because she wanted to look nice on her wedding day, and ended up going blind after a blood clot sent her into a coma.
The report says the woman, from Wisconsin, started taking the blockbuster birth control pill in 2007 because of an advertising blitz by manufacturer Bayer, which made exaggerated claims that it would treat ...
continue reading...The European Medicines Agency has announced it’s investigating reports that Swiss drug maker Roche AG failed to properly report about 80,000 reports of possible side effects in the U.S.
According to a report on Medical Xpress, European regulators spotted the problems during a routine inspection. The inspectors found that Roche had not properly analyzed the accounts of possible side effects to see if they were truly suspected adverse events that needed to be officially reported.
The reports included many different types of ...
continue reading...
The U.S. Centers for Disease Control and Prevention has found no clear link between HIV and use of contraceptives such as the birth control pill and Depo-Provera shots.
According to a Reuters report, recent studies have suggested that the use of hormonal contraceptives could increase the risk of women contracting HIV. But after reviewing the studies, CDC issued a statement to the effect that “the evidence does not suggest” a link ...
continue reading...
Britain’s National Institute for Health and Clinical Excellence has issued an advisory to hospitals, stating that more lives could be saved if medical professionals diagnosed and treated blood clots in the legs and lungs more quickly.
According to a BBC report, NICE is urging hospitals in England and Wales to test for blood clots within 24 hours of identifying symptoms. The report says blood clots in the legs or lungs affected ...
continue reading...
According to a story on WLFI out of Indiana, most members of a U.S. FDA panel said they would not recommend metal-on-metal implants for patients who needed hip replacement surgery.
The report quotes a physician on the panel as saying: “I do not use metal-on-metal hips, and I can see no reason to do so.”
At the FDA’s request, the 18-member panel of experts met for two days this week to discuss ...
continue reading...
A report on the Website for ABC’s Channel 13 out of Ohio deals with attempts by Pfizer Inc. and Bristol-Myers Squibb Co. to get federal regulators to approve their experimental anticlotting drug Eliquis.
The U.S. Food and Drug Administration once again delayed that approval, with the agency saying it wants more information on “data management and verification” from a huge international study examining how well Eliquis prevented strokes in patients ...
continue reading...
